$30.31—Stale · unknown old
NASDAQ • Last print unknown ago
$30.31—Stale · unknown old
Next report
Oct 22 2026in 25 days
EPS estimate
$0.54
Revenue estimate
$47M
EPS beats
8 of last 12
EPS surprise
Each report against the estimate that stood when it landed.
Oct 26 2023Jul 23 2026
| Reported | EPS est | EPS actual | Surprise | Revenue est | Revenue actual | Surprise |
|---|---|---|---|---|---|---|
| Jul 23 2026 | $0.41 | $1.31 | +219.5% | $56M | $69M | +22.9% |
| Apr 23 2026 | $3.91 | $0.40 | -89.8% | $121M | $107M | -11.3% |
| Jan 29 2026 | $0.33 | $0.41 | +24.2% | $41M | $40M | -2.0% |
| Oct 23 2025 | $0.39 | $0.26 | -33.3% | $41M | $38M | -6.4% |
| Jul 24 2025 | $0.31 | $0.41 | +32.3% | $39M | $40M | +3.5% |
| Apr 24 2025 | $0.30 | $0.32 | +6.7% | $39M | $36M | -8.0% |
| Jan 23 2025 | $0.21 | $0.37 | +76.2% | $36M | $34M | -5.8% |
| Oct 24 2024 | $0.22 | $0.24 | +9.1% | $35M | $33M | -4.9% |
| Jul 25 2024 | $0.21 | $0.21 | +0.0% | $36M | $33M | -7.8% |
| Apr 25 2024 | $0.10 | $0.25 | +150.0% | $33M | $33M | -0.2% |
| Jan 25 2024 | $0.17 | ($0.02) | -111.8% | $32M | $29M | -11.4% |
| Oct 26 2023 | $0.20 | $0.16 | -20.0% | $33M | $32M | -2.4% |
Earnings & Revenue Estimates
Forward Growth Estimates (YoY)
FY2027
Rev-7.43%
EPS-58.74%
FY2028
Rev+81.60%
EPS-1.51%
FY2029
Rev+11.15%
EPS+12.37%
Raw consensus estimates (low / average / high) from covering analysts.
Annual
| Metric | FY2026E | FY2027E | FY2028E | FY2029E |
|---|---|---|---|---|
| Revenue Avg | $329M | $304M | $553M | $614M |
| Low | $323M | $299M | $542M | $603M |
| High | $335M | $310M | $563M | $626M |
| EBITDA Avg | $175M | $78M | $79M | $90M |
| Low | $171M | $77M | $78M | $88M |
| High | $179M | $79M | $81M | $92M |
| EBIT Avg | $166M | $68M | $67M | $76M |
| Low | $162M | $68M | $66M | $74M |
| High | $170M | $69M | $69M | $78M |
| Net Income Avg | $136M | $56M | $55M | $62M |
| Low | $132M | $55M | $54M | $60M |
| High | $139M | $56M | $57M | $64M |
| EPS Avg | $6.04 | $2.49 | $2.46 | $2.76 |
| Low | $5.90 | $2.46 | $2.40 | $2.69 |
| High | $6.19 | $2.51 | $2.52 | $2.83 |
| Analysts (Rev / EPS) | 1 / 2 | 1 / 3 | 1 / 1 | 1 / 1 |
Quarterly
| Metric | Q3 2026 | Q4 2026 | Q1 2027 | Q2 2027 | Q3 2027 | Q4 2027 |
|---|---|---|---|---|---|---|
| Revenue Avg | $47M | $49M | $49M | $50M | $52M | $53M |
| Low | $45M | $46M | $46M | $48M | $49M | $50M |
| High | $49M | $50M | $51M | $52M | $54M | $55M |
| EBITDA Avg | $17M | $17M | $18M | $19M | $20M | $21M |
| Low | $16M | $17M | $17M | $18M | $19M | $19M |
| High | $17M | $18M | $18M | $20M | $21M | $21M |
| EBIT Avg | $14M | $15M | $16M | $17M | $18M | $19M |
| Low | $14M | $15M | $15M | $16M | $17M | $17M |
| High | $15M | $15M | $16M | $18M | $19M | $19M |
| Net Income Avg | $12M | $12M | $13M | $14M | $15M | $15M |
| Low | $12M | $12M | $12M | $13M | $14M | $14M |
| High | $12M | $13M | $13M | $15M | $15M | $16M |
| EPS Avg | $0.54 | $0.57 | $0.59 | $0.65 | $0.68 | $0.69 |
| Low | $0.53 | $0.56 | $0.55 | $0.60 | $0.63 | $0.65 |
| High | $0.56 | $0.58 | $0.61 | $0.67 | $0.71 | $0.72 |
| Analysts (Rev / EPS) | 2 / 3 | 2 / 3 | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 |
Earnings Call Transcripts
No earnings transcripts available for CARE
Transcripts may not be available for all companies
Explore More
52-Week Highs Breakout
Stocks breaking to new annual highs
52-Week Lows Oversold
S&P 500 oversold value screener
Trending Momentum
Relative strength momentum leaders
Earnings Calendar
Upcoming earnings dates & reports
S&P 500 Screener
Filter and sort all 500 stocks
Strategy Focus List
Continuous multi-factor scoring & catalyst forensics
Market Movers
Today's biggest gainers and losers